Ah. Sparkes et al., EXPERIMENTAL MICROSPORUM-CANIS INFECTION IN CATS - CORRELATION BETWEEN IMMUNOLOGICAL AND CLINICAL OBSERVATIONS, Journal of medical and veterinary mycology, 33(3), 1995, pp. 177-184
Microsporum canis infection was induced in five of six adult cats by t
he application of mycelium to shaved and mildly abraided skin. The cli
nical course of the disease was monitored over 16 weeks by physical ex
amination and Wood's lamp illumination. The incubation period (time fr
om inoculation to first appearance of infected hairs) varied between 8
and 13 days and was followed by a progressive phase of slow periphera
l expansion of lesions accompanied by scaling, alopecia and skin thick
ening that lasted for approximately 2 weeks. In four of the five cats
the lesions then remained stable for between 1 and 6 weeks before regr
ession occurred, with clinical resolution evident in these cats by 11-
14 weeks post-infection. In one cat disease was more prolonged, with r
egression only beginning at the end of the study, and this cat also de
veloped a satellite lesion. Immunological responses during infection w
ere monitored every 2 weeks and consisted of ELISA to measure serum M.
canis-specific IgG, IgM and IgA antibody concentrations, M. canis ant
igen-specific lymphocyte proliferation assay, and mitogen-induced (Con
A) lymphocyte proliferation assay. In all three immunoglobulin classes
evaluated, a significant (P less than or equal to 0.020) rise in anti
body concentration was seen in response to infection, and occurred ear
liest with the IgM class (2 weeks post-infection). Overall, a heteroge
neous antibody response was found, and changes in antibody concentrati
on showed no clear temporal relationship to recovery from disease. Sma
ll increases (P less than or equal to 0.015) in lymphocyte proliferati
ve responses to M. canis antigen were evident in all cats by 2 to 4 we
eks post-infection, but in contrast to the humoral immune response, a
close temporal relationship was observed between the occurrence of sub
stantially elevated lymphocyte proliferative responses and the onset o
f regression of disease. There was no evidence of non-specific suppres
sion of cellular responses (as assessed by ConA-induced lymphocyte pro
liferation) during the course of disease.